{
    "nctId": "NCT04517370",
    "briefTitle": "CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer",
    "officialTitle": "CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer A Comparative, Randomized, Controlled Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Genitourinary Syndrome of Menopause",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 36,
    "primaryOutcomeMeasure": "Change in dryness",
    "eligibilityCriteria": "Inclusion criteria:\n\n1. Patients diagnosed with breast cancer\n2. Menopause: spontaneous, surgical or chemotherapy induced\n3. One or more GSM Symptoms: dryness, irritation, burning, pain, dyspareunia, dysuria\n4. On exam, clinical findings of atrophy: thin, dry, pale vagina\n5. Age\\>18\n6. Normal Pap smear within 3 years\n\nExclusion criteria:\n\n1. Menstruation\n2. Chemotherapy\n3. Vaginal bleeding which did not underwent evaluation\n4. Concurrent treatment with topical estrogen\n5. Previous vulvar, vaginal or cervical dysplasia\\\\ cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}